These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1112 related articles for article (PubMed ID: 28739725)

  • 21. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
    Zhang GM; Goyal H; Song LL
    Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
    Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
    J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis.
    Wu D; Han B; Guo L; Fan Z
    J Obstet Gynaecol; 2016 Jul; 36(5):615-21. PubMed ID: 26804550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
    Zhang Y; Fang L; Zang Y; Xu Z
    Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data.
    Ding Y; Liu P; Zhang S; Tao L; Han J
    Int J Mol Med; 2018 Jun; 41(6):3597-3603. PubMed ID: 29512771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets.
    Zhang J; Zhou YJ; Yu ZH; Chen AX; Yu Y; Wang X; Cao XC
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome analysis revealed CENPF associated with glioma prognosis.
    Zhang M; Zhang Q; Bai J; Zhao Z; Zhang J
    Math Biosci Eng; 2021 Mar; 18(3):2077-2096. PubMed ID: 33892537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.